Literature DB >> 17595339

Apical junction complex protein expression in the canine colon: differential expression of claudin-2 in the colonic mucosa in dogs with idiopathic colitis.

Alison E Ridyard1, Jeremy K Brown, Susan M Rhind, Roderick W Else, James W Simpson, Hugh R P Miller.   

Abstract

Canine idiopathic lymphocytic-plasmacytic colitis (LPC) is a well-recognized clinical and pathological entity in the dog, associated with altered immune cell populations and cytokine expression profiles. Clinical and experimental data indicate that alterations in the permeability of the intestinal epithelium contribute to the pathogenesis of a range of related conditions. The apical junction complex plays a significant role in regulating epithelial paracellular permeability, and we have characterized the distribution of a number of its component tight junction (ZO-1, occludin, claudin-2) and adherens junction (E-cadherin and beta-catenin) proteins in normal colon and colon from dogs with idiopathic LPC. ZO-1, occludin, E-cadherin, and beta-catenin exhibited a distribution in normal canine colon similar to that described previously in humans and rodents. In contrast to the situation in humans, claudin-2-specific labeling was observed in the normal canine colonic crypt epithelium, decreasing in intensity from the distal to the proximal crypt and becoming barely detectable at the luminal surface of the colon. There was little evidence for significant changes in ZO-1, occludin, E-cadherin, or beta-catenin expression in dogs affected by idiopathic LPC. However, claudin-2 expression markedly increased in the proximal crypt and luminal colonic epithelium in affected dogs, suggesting a role in the pathogenesis of canine LPC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17595339     DOI: 10.1369/jhc.7A7211.2007

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  15 in total

1.  Matrix metalloproteinase 9-induced increase in intestinal epithelial tight junction permeability contributes to the severity of experimental DSS colitis.

Authors:  Prashant Nighot; Rana Al-Sadi; Manmeet Rawat; Shuhong Guo; D Martin Watterson; Thomas Ma
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-10-29       Impact factor: 4.052

2.  Phosphorylation of claudin-2 on serine 208 promotes membrane retention and reduces trafficking to lysosomes.

Authors:  Christina M Van Itallie; Amber Jean Tietgens; Kirsten LoGrande; Angel Aponte; Marjan Gucek; James M Anderson
Journal:  J Cell Sci       Date:  2012-07-23       Impact factor: 5.285

3.  Claudin-2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrences.

Authors:  Siker Kimbung; Anikó Kovács; Pär-Ola Bendahl; Per Malmström; Mårten Fernö; Thomas Hatschek; Ingrid Hedenfalk
Journal:  Mol Oncol       Date:  2013-10-14       Impact factor: 6.603

4.  Claudin-2-dependent changes in noncharged solute flux are mediated by the extracellular domains and require attachment to the PDZ-scaffold.

Authors:  Christina M Van Itallie; Jennifer Holmes; Arlene Bridges; James Melvin Anderson
Journal:  Ann N Y Acad Sci       Date:  2009-05       Impact factor: 5.691

5.  Chloride channel ClC-2 is a key factor in the development of DSS-induced murine colitis.

Authors:  Prashant Nighot; Karen Young; Meghali Nighot; Manmeet Rawat; Eui J Sung; Nitsan Maharshak; Scott E Plevy; Thomas Ma; Anthony Blikslager
Journal:  Inflamm Bowel Dis       Date:  2013-12       Impact factor: 5.325

6.  Claudin-2 expression increases tumorigenicity of colon cancer cells: role of epidermal growth factor receptor activation.

Authors:  P Dhawan; R Ahmad; R Chaturvedi; J J Smith; R Midha; M K Mittal; M Krishnan; X Chen; S Eschrich; T J Yeatman; R C Harris; M K Washington; K T Wilson; R D Beauchamp; A B Singh
Journal:  Oncogene       Date:  2011-03-07       Impact factor: 9.867

7.  Targeted colonic claudin-2 expression renders resistance to epithelial injury, induces immune suppression, and protects from colitis.

Authors:  R Ahmad; R Chaturvedi; D Olivares-Villagómez; T Habib; M Asim; P Shivesh; D B Polk; K T Wilson; M K Washington; L Van Kaer; P Dhawan; A B Singh
Journal:  Mucosal Immunol       Date:  2014-03-26       Impact factor: 7.313

Review 8.  Mechanisms of Intestinal Epithelial Barrier Dysfunction by Adherent-Invasive Escherichia coli.

Authors:  Ali Shawki; Declan F McCole
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2016-10-22

Review 9.  Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics.

Authors:  Luca Pastorelli; Carlo De Salvo; Joseph R Mercado; Maurizio Vecchi; Theresa T Pizarro
Journal:  Front Immunol       Date:  2013-09-17       Impact factor: 7.561

10.  Comparison of microbiological, histological, and immunomodulatory parameters in response to treatment with either combination therapy with prednisone and metronidazole or probiotic VSL#3 strains in dogs with idiopathic inflammatory bowel disease.

Authors:  Giacomo Rossi; Graziano Pengo; Marco Caldin; Angela Palumbo Piccionello; Jörg M Steiner; Noah D Cohen; Albert E Jergens; Jan S Suchodolski
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.